VolitionRx Ltd. is looking to raise gross proceeds of about $8.4 million through its public offering of common stock.
The life sciences company is offering 3.5 million common shares at $2.4 apiece and has granted the underwriters an overallotment option to acquire 525,000 additional shares.
The offering is expected to close March 13, subject to the satisfaction of customary closing conditions.
Oppenheimer & Co. Inc. is acting as the sole book-running manager, while National Securities Corp. is acting as a co-manager for the offering.
